Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Apr;27(4):578–582. doi: 10.1128/aac.27.4.578

Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.

M C Rogge, C A Johnson, S W Zimmerman, P G Welling
PMCID: PMC180099  PMID: 4004194

Abstract

Expressions are presented to describe the absorption and also clearance of drugs administered into the peritoneal cavity of patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Application of the expressions to vancomycin kinetics in five male CAPD patients showed that therapeutic levels of vancomycin can readily be achieved and maintained in the systemic circulation by administering the appropriate loading and maintenance doses. The intrinsic peritoneal clearance of vancomycin reported here is higher than the apparent clearances reported previously, averaging 300 to 500 ml/min under the conditions used in this study. The low apparent clearances previously reported are useful clinically although they do not represent the true efficiency of vancomycin removal by CAPD. The degree to which apparent clearance underestimates the true intrinsic clearance is exponentially related to the dwell time of dialysate in the peritoneum. Intraperitoneal administration is a practical alternative to other routes for CAPD patients needing antibiotic or other therapy.

Full text

PDF
578

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blevins R. D., Halstenson C. E., Salem N. G., Matzke G. R. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother. 1984 May;25(5):603–606. doi: 10.1128/aac.25.5.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown S. T., Ahearn D. J., Nolph K. D. Reduced peritoneal clearances in scleroderma increased by intraperitoneal isoproterenol. Ann Intern Med. 1973 Jun;78(6):891–894. doi: 10.7326/0003-4819-78-6-891. [DOI] [PubMed] [Google Scholar]
  3. Bunke C. M., Aronoff G. R., Brier M. E., Sloan R. S., Luft F. C. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther. 1983 Nov;34(5):631–637. doi: 10.1038/clpt.1983.225. [DOI] [PubMed] [Google Scholar]
  4. Dunham C. B., Hak L. J., Hull J. H., Mattocks A. M. Enhancement of peritoneal dialysis clearance with docusate sodium. Kidney Int. 1981 Nov;20(5):563–568. doi: 10.1038/ki.1981.177. [DOI] [PubMed] [Google Scholar]
  5. Nolph K. D., Popovich R. P., Ghods A. J., Twardowski Z. Determinants of low clearances of small solutes during peritoneal dialysis. Kidney Int. 1978 Feb;13(2):117–123. doi: 10.1038/ki.1978.17. [DOI] [PubMed] [Google Scholar]
  6. Pancorbo S., Comty C. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis. Nephron. 1982;31(1):37–39. doi: 10.1159/000182611. [DOI] [PubMed] [Google Scholar]
  7. Rubin J., Humphries J., Smith G., Bower J. Antibiotic activity in peritoneal dialysate. Am J Kidney Dis. 1983 Nov;3(3):205–208. doi: 10.1016/s0272-6386(83)80063-8. [DOI] [PubMed] [Google Scholar]
  8. Sewell D. L., Golper T. A. Stability of antimicrobial agents in peritoneal dialysate. Antimicrob Agents Chemother. 1982 Mar;21(3):528–529. doi: 10.1128/aac.21.3.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Somani P., Shapiro R. S., Stockard H., Higgins J. T. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther. 1982 Jul;32(1):113–121. doi: 10.1038/clpt.1982.134. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES